Indigenous Antibiotic Nafithromycin | 21 Nov 2024

Source: PIB 

Recently, India launched Nafithromycin, India’s first indigenous antibiotic aimed at tackling Antimicrobial Resistance (AMR). 

• Nafithromycin was developed with support from the Biotechnology Industry Research Assistance Council (BIRAC) and brought to market by Wockhardt under the brand name Miqnaf. 
  • Nafithromycin is the first new antibiotic in its class in over 30 years, marking a breakthrough in the fight against AMR. 
• It is designed to treat Community-Acquired Bacterial Pneumonia (CABP), caused by drug-resistant bacteria like Streptococcus pneumoniae. 
• The launch coincides with World AMR Awareness Week (18-24 November) 2024 with the theme 'Preventing Antimicrobial Resistance Together'.  

Read More: Antimicrobial Resistance